Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer

NCT00542191 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Enrollment Completed

Conditions

Breast Cancer

Interventions

DRUG: Doxorubicin / Cyclophosphamide / Paclitaxel / Carboplatin
PROCEDURE: Definitive Surgery
RADIATION: Radiotherapy

Sponsor

Leo W. Jenkins Cancer Center